BIFCA
The Brief International Functional Capacity Assessment (BIFCA) is a performance-based measure of functional capacity that assesses an individual’s ability to perform key tasks of daily living. It is designed to be used as a co-primary outcome measure in clinical trials of cognition-enhancing drugs for adults with schizophrenia and related disorders.
- Developed using a consensus process and collection of empirical data
- Demonstrated relationship to cognitive deficits and functional outcomes
- Product of multiple studies investigating psychometric properties and cross-cultural adaptability of co-primary measures
MCCB™
The MATRICS™ Consensus Cognitive Battery (MCCB™) is intended to provide a relatively brief evaluation of key cognitive domains relevant to schizophrenia and related disorders, and was designed to address the following purposes:
- As an outcome measure for clinical trials of treatments designed to improve cognition in schizophrenia and related disorders
- As an outcome measure for studies of cognitive remediation
- As a measure of cognitive change in repeated testing applications
- As a cognitive reference point for non-intervention studies of schizophrenia and related disorders
How to Order
To order the MCCB™ or BIFCA, please visit the “How to Order” page.
Address: 11693 San Vicente Blvd. #322, Los Angeles, CA 90049 | Fax: (310) 312-1535 | Email: matricsassessment@gmail.com